INVESTOR DEADLINE TUESDAY: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLT
February 14, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and ...
Applied Materials Navigates China Slowdown, Analysts See Early Recovery Despite Soft Guidance
Analysts revised price targets for Applied Materials after Q1 results, beating estimates on revenue and EPS, but Q2 guidance fell short. Buy-rated with price targets of $195, $217, and $225.